Reuters

(Reuters) - Pfizer beat first-quarter profit estimates on Wednesday, benefiting from cost cuts and strong sales for its pneumonia and respiratory synctitial virus vaccines.

The U.S. drugmaker posted an adjusted profit of 82 cents per share, while analysts on average were expecting it to earn 52 cents, according to LSEG data.

(Reporting by Bhanvi Satija and Sriparna Roy in Bengaluru; Editing by Arun Koyyur)

(Reuters) -Estee Lauder raised its annual profit forecast and beat Wall Street targets for third-quarter sales on Wednesday, as demand for the MAC lipstick maker's higher-priced skincare and fragrances rebounded in the U.S. and Asia Pacific markets.

Shares of the New York-based company were up 3.8% in premarket trading.

The results hint at a recovery in demand for beauty and cosmetic products in the U.S. after a long bout of inflation had... (continue reading...)

(Reuters) -CVS Health Corp slashed its annual profit forecast and missed Wall Street estimates for first-quarter earnings on Wednesday, as elevated demand for non-urgent procedures increased medical costs at its health insurance business.

The U.S. healthcare giant cut its per-share adjusted earnings forecast for 2024 to at least $7.00 from at least $8.30, adding it anticipates the surge in medical procedures at its unit that houses health insurer Aetna to... (continue reading...)

By David Swanson

LOS ANGELES (Reuters) - Violent clashes erupted early on Wednesday morning on the campus of the University of California in Los Angeles between pro-Palestinian protesters and a group of counter-demonstrators supporting Israel.

Police were deployed to the campus after the Israel supporters tried to tear down a pro-Palestinian protest encampment, according to the UCLA student newspaper Daily Bruin.

Footage... (continue reading...)

By Yuvraj Malik

(Reuters) - Apple's plan to add generative AI to its iPhones and revive sagging sales in the crucial Chinese market will be in focus on Thursday, when the tech giant is expected to report its biggest quarterly revenue decline in more than a year.

Long considered a must-own stock on Wall Street, Apple shares have underperformed other Big Tech companies in recent months, falling more than 10% year to date as fears mount... (continue reading...)